VEGFA and diabetic retinopathy: In contrast, the impact of an intensified early treatment during the first year on visual gains [8, 24, 25] and improved diabetic retinopathy severity scores (DRSS) with anti-VEGF drugs had not been demonstrated until late 2013 [13, 14] and thus, may have had less impact.